FDA Advisory Committee votes ‘No’ on MAPS/Lykos MDMA-assisted therapy approval


01:00:34 MIN LISTEN

In today’s episode of the Psychedelic Therapy Frontiers podcast Dr. Steve Thayer and Dr. Reid Robison  talk about the recent FDA psychopharmacologic drugs advisory committee meeting that resulted in a majority vote against the approval of MDMA-assisted therapy for PTSD based on MAPS/Lykos study data. They discuss what the committee’s concerns were, the Institute for Clinical and Economic Review’s (ICER) criticisms of the studies, the challenges of conducting psychedelic clinical trials, functional unblinding, how research and rater bias affects study data, and much more.



Learn more about our podcast at https://numinus.com/podcast/

Learn more about psychedelic therapy training opportunities at https://numinus.com/training/

Learn more about our clinical trials at https://www.numinus.com/clinical-trials

Learn more about Numinus at https://numinus.com/

Email us at ptfpodcast@numinus.com


Follow us on Instagram:



Would you like to be a guest
on our podcast?

Enter your info and we'll reach out to you asap.


Would you like to be a guest on our podcast?

By signing up you consent to the Privacy Policy & Terms of Use.
Call us toll-free 1-833-NUMINUS (686-4687)
crosschevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram